http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2484941-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 1981-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1981-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2484941-A1
abstract THE INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE. THE COMPOSITION OF THE INVENTION CONTAINS A QUANTITY OF 2- (3-TERTIO-BUTYLAMINO-2-HYDROXYPROPYLTHIO) -4- (5-CARBAMOYL-2-THIENYL) -THIAZOLE OR AN ACID ADDITIONAL SALT OF THIS COMPOUND, EFFECTIVE TO LOWER THE INTRA-OCULAR PRESSURE OF THE EYE. APPLICATION TO THE TREATMENT OF GLAUCOMA OR EYE HYPERTENSION.
priorityDate 1980-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410637400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411471813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71081
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4418048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406954885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409982726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID943
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6419706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410072000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5288227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31348

Total number of triples: 55.